Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
8.09
0.00 (0.00%)
Sep 3, 2025, 8:44 AM - Market open
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of $6.86 million as of September 3, 2025. Its market cap has increased by 4.80% in one year.
Market Cap
6.86M
Enterprise Value
3.39M
1-Year Change
4.80%
Ranking
Category
Stock Price
$8.09
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from $323.99M to $6.86M, a decrease of -97.88%. That is a compound annual growth rate of -19.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 6.86M | 10.64% |
| Dec 30, 2024 | 6.20M | -15.53% |
| Dec 29, 2023 | 7.34M | -34.64% |
| Dec 30, 2022 | 11.23M | -73.95% |
| Dec 30, 2021 | 43.12M | -28.43% |
| Dec 30, 2020 | 60.25M | 34.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.01B |
| Johnson & Johnson | 428.83B |
| AbbVie | 374.37B |
| UnitedHealth Group | 279.67B |
| Novo Nordisk | 248.91B |
| AstraZeneca | 247.16B |
| Novartis AG | 244.04B |
| Abbott Laboratories | 228.80B |